|
Postings for Healthcare Providers
|
Date Posted
|
|
A Contrarian’s View on the 2018 Chest Guideline for Antithrombotic Therapy in Atrial Fibrillation
|
November 2018
|
|
Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future?
|
September 2017
|
|
Seeking Patients Taking Warfarin (Coumadin) for a Brief Survey
|
March 2017
|
|
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
|
January 2013
|
|
Deep Vein Thrombosis and Pulmonary Embolism Brochure from Clot Connect
|
January 2013
|
|
Alliance for Aging Research Releases Survey of AFib Patients 65+ that Finds Active Participation in Treatment Decisions
|
November 2012
|
|
Novel Anticoagulants Should not Replace Warfarin; Head-to-Head Trial Needed
|
September 2012
|
|
Assessing Stroke & Bleeding Risk in Atrial Fibrillation: Expert Consensus
|
July 2012
|
|
The allure of endovascular intervention for stroke prevention fails to de
|
July 2012
|
|
New Chest Guidelines Available Now
|
February 2012
|
|
Rivaroxaban vs a Vitamin K antagonist (EINSTEIN-DVT trial)
|
July 2011
|
|
FDA approves Pradaxa (dabigatran) to prevent stroke in people with atrial
|
October 2010
|
|
Warfarin Better than Dabigatran and Vice Versa in Some Patients with Atri
|
October 2010
|
|
FDA Recommends Dabigatran Approval: Agree with no ASA, still skeptical on
|
October 2010
|
|
Subcutaneous Direct Thrombin Inhibitor (Desirudin) Approved for Preventio
|
March 2010
|
|
Dabigatran vs. Warfarin in Atrial Fibrillation; Reluctant to Rely on RE-L
|
March 2010
|
|
New study and accompanying editorial suggest that warfarin may be indicat
|
January 2010
|
|
Warfarin (Coumadin) Video from AHRQ
|
October 2009
|
|
INR Patient Self Testing Video Demo
|
October 2009
|
|
Study Finds No Benefit of Low-dose Vitamin K Administration for High INRs
|
May 2009
|
|
IM (Intramuscular) Injections for Warfarin-Treated Patients: What Should
|
March 2009
|
|
Heparin Contamination
|
December 2008
|
|
Computer-assisted dosing programs perform well when used by experienced c
|
July 2008
|
|
Warfarin more effective and at least as safe as low dose aspirin in elder
|
September 2007
|
|
Poor adherence as a potential source of poor anticoagulation control
|
April 2007
|
|
Should 3rd Generation Birth Control Pills be Banned? - Opposition to a Pe
|
March 2007
|
|
Should we be treating more patients with warfarin (Coumadin)?
|
March 2007
|
|
Can better INR control be achieved, and if so, how will new anticoagulant
|
March 2007
|
|
PCC Products and Reversing Warfarin
|
March 2007
|
|
New National Performance Measures Issue Mandate to Reduce Incidence of De
|
February 2007
|
|
DVT (Deep Vein Thrombosis) Awareness Month: DVT Awareness by Design
|
February 2007
|
|
Telephone Versus In-Office Anticoagulation Management
|
January 2007
|
|
Diagnosis, risk-stratification, and management of patients with antiphosp
|
July 2006
|
|
New Guidelines to Reduce DVT Risk in Cancer Patients
|
April 2006
|
|
Long-term warfarin may increase osteoporotic fractures in men but not wom
|
March 2006
|
|
Major Bleeding Events Lead to Under Use of Anticoagulation in Atrial Fibr
|
February 2006
|
|
Daily Low-dose Vitamin K Supplementation Stabilizes INRs
|
February 2006
|
|
Poor Early Anticoagulation Control Associated with Near 3-fold Increase i
|
January 2006
|
|
New Data Fuels Continued Controversy About Anti-Phospholipid Antibody (AP
|
November 2005
|
|
Should I stop my patients warfarin prior to a dental procedure?
|
October 2005
|
|
Appropriate Use of Anticoagulation in Atrial Fibrillation Patients Dramat
|
October 2005
|
|
Where can I find an anticoagulation expert near my home or office?
|
October 2005
|
|
Advanced age affects major bleeding and major thromboembolic rates in pat
|
October 2005
|
|
Anticoagulation Training Programs
|
September 2005
|
|
Warfarin and Aspirin Combination in Acute Coronary Syndrome
|
August 2005
|
|
Largest study yet confirms benefits of clinical pharmacy managed anticoag
|
May 2005
|
|
NIH Conference on Dietary Supplements, Coagulation, and Antithrombotic Th
|
March 2005
|
|
Self-Management of Oral Anticoagulation
|
March 2005
|
|
Exanta not Recommended by FDA Advisory Panel, Causes M.I.s?
|
September 2004
|
|
Genetic Variation in Warfarin Metabolism
|
September 2004
|
|
New Supplement Devoted to Factor Xa Inhibitors (fondaparinux)
|
August 2004
|
|
Excessive Anticoagulation Associated with Increased Mortality and Morbidi
|
August 2004
|
|
Is Warfarin-Induced Bleeding Increasing?
|
August 2004
|
|
Anticoagulation in Special Populations
|
August 2004
|
|
Treatment of Deep Vein Thrombosis
|
August 2004
|
|
An Overview of Anticoagulants, Antiplatelet Agents, and the Combination i
|
May 2004
|
|
The Use of Low Dose Vitamin K to Stabilize INR Fluctuation During Warfari
|
May 2004
|
|
Hot Topic: The Optimal Range of Oral Anticoagulation in Patients with Mec
|
March 2004
|